MedAssets (NASDAQ: MDAS) and Barracuda Networks (NYSE:CUDA) are both technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, profitabiliy and earnings.

Profitability

This table compares MedAssets and Barracuda Networks’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MedAssets -1.18% -2.00% -0.54%
Barracuda Networks 2.81% -1,770.56% 3.79%

Analyst Recommendations

This is a summary of recent recommendations and price targets for MedAssets and Barracuda Networks, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MedAssets 0 0 0 0 N/A
Barracuda Networks 1 5 10 0 2.56

Barracuda Networks has a consensus target price of $26.64, suggesting a potential upside of 17.99%. Given Barracuda Networks’ higher possible upside, analysts plainly believe Barracuda Networks is more favorable than MedAssets.

Insider & Institutional Ownership

63.7% of Barracuda Networks shares are held by institutional investors. 13.9% of Barracuda Networks shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares MedAssets and Barracuda Networks’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
MedAssets N/A N/A N/A N/A N/A
Barracuda Networks $360.17 million 3.32 $36.87 million $0.19 118.85

Barracuda Networks has higher revenue and earnings than MedAssets.

Summary

Barracuda Networks beats MedAssets on 7 of the 8 factors compared between the two stocks.

MedAssets Company Profile

MedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company’s technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company’s solutions across decentralized health care organizations, providing standardization and compliance.

Barracuda Networks Company Profile

Barracuda Networks, Inc. designs and delivers security and data protection solutions. The Company offers cloud-enabled solutions that enable customers to address security threats, manage network performance, and protect and store their data. Its solutions are designed to manage information technology operations for its customers. Its security solutions include Barracuda Email Security, The Barracuda Web Security Gateway, Barracuda NextGen Firewalls, The Barracuda Web Application Firewall, The Barracuda Load Balancer ADC and The Barracuda SSL VPN. Its data protection solutions provide solutions for on-premises and cloud-based archiving and backup. Its data protection solutions include Barracuda Backup, Barracuda Message Archiver and CudaSign. Its solution suites combine its security and data protection offerings into services designed for cloud platforms and managed services environments. Its solution suites include Barracuda Essentials for Office 365 and Intronis ECHOplatform.

Receive News & Ratings for MedAssets Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAssets Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.